Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Cyclosporine in 5-FU Refractory Advanced Colorectal Cancer
NCT00003950Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jan 2000
- Primary completion
- Dec 2001
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in colorectal cancer (CRC), sponsored by University of Chicago. Started Jan 2000; status: completed.
02
Drugs
cyclosporine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003950.